CHAD BLANKENSHIP: Open Payments
NPI 1598062879 · CONCORD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,395 in 67 payments from 9 companies in 2025. Trend: 2023 $891 · 2024 $704 · 2025 $1,395
Food & beverage: $1,283Education: $111
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 19 | $408 |
| Teva Pharmaceuticals USA, Inc. | 18 | $394 |
| Janssen Pharmaceuticals, Inc | 9 | $187 |
| Otsuka America Pharmaceutical, Inc. | 9 | $165 |
| Vanda Pharmaceuticals Inc. | 3 | $64 |
| Lundbeck LLC | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Alkermes, Inc. | 2 | $44 |
| ABBVIE INC. | 1 | $18 |
Products named: COBENFY, INVEGA SUSTENNA, ABILIFY ASIMTUFII, AUSTEDO XR, UZEDY, FANAPT, REXULTI, CAPLYTA.
Industry payments across NC — which companies pay providers there.
